Robin Jones to Drug Evaluation, Preclinical
This is a "connection" page, showing publications Robin Jones has written about Drug Evaluation, Preclinical.
Connection Strength
0.388
-
Probabilistic modeling of personalized drug combinations from integrated chemical screen and molecular data in sarcoma. BMC Cancer. 2019 Jun 17; 19(1):593.
Score: 0.165
-
Olaratumab for the treatment of soft-tissue sarcoma. Future Oncol. 2017 Oct; 13(24):2151-2157.
Score: 0.145
-
Utility of dexrazoxane for the reduction of anthracycline-induced cardiotoxicity. Expert Rev Cardiovasc Ther. 2008 Nov; 6(10):1311-7.
Score: 0.079